Apricus Bio (APRI) Pops on Vitaros Marketing News
Apricus Biosciences (Nasdaq: APRI) is seeing a pop following the announcement that its NexMed subsidiary entered a Vitaros marketing agreement in Germany.
Shares are up 5.3 percent following the news.
For more color, click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Shares are up 5.3 percent following the news.
For more color, click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- Cree (CREE) Volatility Elevated as CFO Slide Continues
- Morgan Stanley (MS) Shares Pressured on Questionable Facebook (FB) Tactics; Hits Fresh 6-Month Low
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
